Darmstadt, Germany, January 30, 2015 – Merck KGaA, Darmstadt, Germany, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials today announced that Andreas Stickler (43) has been appointed as new Head of Controlling of the Healthcare Business Sector. Roman Morten Werth (38) will succeed Andreas Stickler in his current position as Head of Mergers & Acquisitions (M&A). The changes will take effect on Feb. 1, 2015.
“We’re delighted that two key positions in our Finance Function will be filled with internal managers who bring the experience and the track record to ensure quality and continuity alike,” said Marcus Kuhnert, Chief Financial Officer and Member of the Executive Board of Merck KGaA, Darmstadt, Germany.
In his new role, Andreas Stickler will be responsible for the controlling of the largest of the three Business Sectors, which have been introduced on Jan. 1, 2015. In addition to the biopharmaceutical business, the Business Sector Healthcare also comprises the businesses Consumer Health, Biosimilars and Allergopharma. Andreas Stickler has headed the M&A department since 2008 and in that role led major transactions, including the takeover of Millipore (2010), AZ Electronic Materials (2014) and the planned acquisition of Sigma Aldrich (announced 2014). He joined Merck KGaA, Darmstadt, Germany, in 2002, following positions at Degussa, Aventis and Hoechst. Roman Werth joined the M&A department at Merck KGaA, Darmstadt, Germany, in 2008 and has played a key role in executing all major M&A projects. Prior to his career atthe company, he had worked several years at M&A departments of Siemens and Continental AG. In their new positions, Andreas Stickler and Roman Werth will both report directly to Marcus Kuhnert.
Since 2004 Merck KGaA, Darmstadt, Germany, has invested around €18 billion in acquisitions and generated around € 7 billion through divestments. The most recent transactions included the € 1.9 billion takeover of AZ Electronic Materials, a producer of high-tech electronic materials for displays. In September 2014, the company announced an agreement to acquire Sigma-Aldrich for around € 13 billion to combine it with the Life Science Tools business of Merck KGaA, Darmstadt, Germany, and form one of the leading life science companies globally. Both transactions have marked major milestones in the company’s “Fit for 2018” transformation and growth program aimed at building three strong platforms for sustainable, profitable growth.